Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,544,900
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
6,398,618
-
Shares change
-
+502,343
-
Total reported value, excl. options
-
$5,759,296
-
Value change
-
+$306,125
-
Number of buys
-
30
-
Number of sells
-
17
-
Price
-
$0.9000
Institutional Holders of FibroBiologics, Inc. - Common Stock (FBLG) as of Q1 2025
As of 31 Mar 2025 FibroBiologics, Inc. - Common Stock (FBLG) had 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,398,618 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Cascade Financial Partners, LLC, NORTHERN TRUST CORP, UBS Group AG, Optivise Advisory Services LLC, Requisite Capital Management, LLC, and Cerity Partners LLC.
This table shows 63 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.